Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Work from home jobs provide flexible options to help with debt. Explore opportunities that allow you to earn while managing your schedule.
21,123 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Meta Platforms rides a pivotal thesis: AI compute demand is real, scarce, and driving a company-wide pivot to data in...
Two AI hardware names—Astera Labs and Navitas Semiconductor—shine for investors through very different revenue paths....
As Apple gears up for a major investor update, investors face a timing decision. This article provides a practical fr...
A Paychex executive recently sold a small stake, raising questions about the stock's direction. This article explains...
Semiconductors took the spotlight as Micron sparked a broader tech rally. TheNasdaq led gains while the S&P 500 and D...
When a company earns a spot in the Nasdaq-100, investors watch for clues about future moves. This article digs into t...
The S&P 500 nudged higher as traders brace for a pivotal Federal Reserve policy decision. Investors weigh rate paths,...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...
Two heavyweight banks reported solid Q4 2025 results, but investors remain focused on dividends, buybacks and how eac...
A widening Epstein-related inquiry fuels renewed scrutiny of global power players. As whispers of the former Prince A...